CYTOKINETICS INC — Director's Dealing 2019

Mar 4, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2019-02-26

Reporting Person: Malik Fady Ibraham (EVP Research & Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-26	Common Stock	A	50000	$0.0	Acquired	134067	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-26	Incentive Stock Option (right to buy)	$7.14	A	13925	Acquired	2029-02-26	Common Stock (13925)	Direct
2019-02-26	Non-Qualified Stock Option (right to buy)	$7.14	A	66075	Acquired	2029-02-26	Common Stock (66075)	Direct

Footnotes

F1: This award shall vest over three years in annual installments: 40% one year from the date of grant, 40% two years from the date of grant and 20% three years from the date of grant.

F2: This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant.